申请人:ADIR ET COMPAGNIE
公开号:US20020161228A1
公开(公告)日:2002-10-31
A compound selected from those of formula (I):
1
wherein:
W represents optionally substituted naphthyl, or group of formula Y
2
as defined in the description,
n represents an integer from 1 to 6 inclusive,
Z represents single bond, oxygen, or optionally substituted nitrogen,
A and Q each represent CH or nitrogen,
M, together with carbon of phenyl to which it is bonded, represents thienyl, furyl, pyrrolyl or oxopyrrolyl,
its isomers, and pharmaceutically-acceptable acid or base addition salts thereof, and medicinal products containing the same are useful in the treatment of some CNS disorders.
从式(I)中选择的化合物:其中:W代表可选取代的萘基或式Y2所定义的基团,n表示从1到6的整数,包括Z代表单键,氧或可选取代的氮,A和Q各自代表CH或氮,M与其结合的苯环上的碳一起,代表噻吩基,呋喃基,吡咯基或氧代吡咯基,其异构体和药学上可接受的酸或碱加盐物,以及含有它们的药物制品在治疗某些中枢神经系统疾病方面是有用的。